Loading
Latest filing published 29 Apr 2026 for Baijin Life Science Holdings Ltd..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
SU Yaoyao (chief executive) discloses dealings in Baijin Life Science Holdings Ltd. to HKEX. Over a trading history stretching from 26 March 2024 to 24 April 2026, the count stands at 4 filings.
On the open market, the record shows 1 purchase and 2 sales. The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
The record was last updated on 29 April 2026 with an open-market purchase in Baijin Life Science Holdings Ltd. Typically, a trade is published a median of 6 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration